C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines

Author：

E-ISSN： 1791-2423|46|5|2231-2240

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.5, 2015-01, pp. : 2231-2240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leptin induces cell proliferation and reduces cell apoptosis by activating c-myc in cervical cancer

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2291-2296

Spandidos Publications

Access to resources Recommend Favorite

Opposite effects of antimicrotubule agents on c-myc oncogene expression depending on the cell lines used

By Bourgarel-Rey

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 1043-1049

Elsevier

Access to resources Recommend Favorite

Combination Antigene Therapy Targeting c-myc and c-erbB 2 in the Ovarian Cancer COC 1 Cell Line

By Fei R. Shaoyang L.

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 40-44

Elsevier

Access to resources Recommend Favorite

c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 305-326

Bentham Science Publishers

Access to resources Recommend Favorite

c-Myc down-regulation is involved in proteasome inhibitor-mediated enhancement of radiotherapeutic efficacy in non-small cell lung cancer

By Jung Joohee Kim Eun-Jin Chung Hye Kyung Park Heon Joo Jeong Seong-Yun Choi Eun Kyung

International Journal of Oncology, Vol. 40, Iss. 2, 2012-02 ,pp. : 385-390

Spandidos Publications

Access to resources Recommend Favorite